Daniel R. Chevallard - CFO and COO at Viracta Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CFO and COO
Issuer Symbol
VIRX
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Daniel R. Chevallard since 10 Feb 2025

Holdings reported by Daniel R. Chevallard for Viracta Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 102,306 $74,908 $0.7322 27 Feb 2024 Direct
Restricted Stock Units 34,444 $16,988 $0.4932 25 Feb 2024 Direct Common Stock
Stock Option (Right to Buy) 200,000 12 Mar 2024 Direct Common Stock

Transactions reported by Daniel R. Chevallard for Viracta Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.